CV5 Capital has announced a partnership with Enzyme to launch institutional tokenized fund solutions using Enzyme Onyx technology. This collaboration aims to provide professional and institutional investors with tokenized hedge funds, digital asset portfolios, and treasury products. The funds will be managed under CV5 Digital SPC, adhering to the Cayman Islands Monetary Authority regulations, and will feature real-time asset visibility and automated net asset value updates.
The initial offerings will include market-neutral digital asset funds, Bitcoin treasury tools, and tokenized credit opportunities. By combining CV5's regulated infrastructure with Enzyme's decentralized technology, the partnership seeks to enhance the efficiency and transparency of fund management for institutional clients.
CV5 Capital and Enzyme Collaborate on Institutional Tokenized Fund Solutions
Disclaimer: The content provided on Phemex News is for informational purposes only. We do not guarantee the quality, accuracy, or completeness of the information sourced from third-party articles. The content on this page does not constitute financial or investment advice. We strongly encourage you to conduct you own research and consult with a qualified financial advisor before making any investment decisions.
